Company Filing History:
2 out of 1,743 
2 out of 5,076 
2 out of 11 
Years Active: 2014-2015
Title: Innovations of Ignacio Moriyon
Introduction
Ignacio Moriyon is a notable inventor based in Pamplona, Spain. He has made significant contributions to the field of microbiology, particularly in the development of modified gram-negative bacteria for use as vaccines. His work has led to the filing of two patents that showcase his innovative approach to vaccine development.
Latest Patents
Moriyon's latest patents focus on the use of gram-negative bacteria that carry an inactivated gene encoding a glycosyltransferase. This gene is involved in the synthesis of the core of the lipopolysaccharide (LPS) of these bacteria. The modification results in a LPS with a modified core, which has attenuated virulence but is capable of inducing sufficient humoral immunity for effective vaccination of the host. This innovative approach has the potential to enhance vaccine efficacy and safety.
Career Highlights
Throughout his career, Ignacio Moriyon has worked with prestigious research institutions, including the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His experience in these organizations has contributed to his expertise in vaccine research and development.
Collaborations
Moriyon has collaborated with notable colleagues such as Jean-Pierre Gorvel and Vilma Arce Gorvel. These collaborations have likely enriched his research and expanded the impact of his innovations in the field.
Conclusion
Ignacio Moriyon's contributions to vaccine development through his innovative use of modified gram-negative bacteria highlight his role as a significant inventor in the field of microbiology. His patents reflect a commitment to advancing public health through scientific research and innovation.